EMCDDA Home
  • EN

Table TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2008 or most recent year available [see all tables in this series...]

Part (v) New inpatient clients, age distribution by primary drug (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge known (base)Age not known
Opioids0.26.823.330.919.09.25.84.829.5366724
Cocaine0.05.419.424.522.913.710.14.131.05424
Stimulants1.521.032.021.611.65.52.73.926.0116411
Hypnotics and sedatives1.84.310.810.812.410.37.941.840.94452
Hallucinogens7.114.350.014.30.00.07.17.126.1140
Volatile substances13.948.616.211.06.41.22.30.620.81731
Cannabis 1.625.128.519.510.66.04.14.626.113725
Other substances 1.36.813.214.515.48.510.329.937.72341
Total1.113.024.824.815.88.25.57.429.2761148

Notes:

 The countries supplying data are: 

 BG, CZ, DK, DE, IE, EL, FR, CY, LV,HU, AT, RO, SK, FI, SE, UK, HR, TR.   

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-104 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2009 — Table TDI outpatient and inpatient treatment centres. 

(see the help page for information about formats etc.)

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Wednesday, 14 July 2010